DE2748466A1 - 4a-aryloctahydro-1h-2-pyrindine - Google Patents

4a-aryloctahydro-1h-2-pyrindine

Info

Publication number
DE2748466A1
DE2748466A1 DE19772748466 DE2748466A DE2748466A1 DE 2748466 A1 DE2748466 A1 DE 2748466A1 DE 19772748466 DE19772748466 DE 19772748466 DE 2748466 A DE2748466 A DE 2748466A DE 2748466 A1 DE2748466 A1 DE 2748466A1
Authority
DE
Germany
Prior art keywords
group
pyrindine
carbon atoms
formula
octahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772748466
Other languages
German (de)
English (en)
Inventor
Dennis Michael Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE2748466A1 publication Critical patent/DE2748466A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DE19772748466 1976-11-02 1977-10-28 4a-aryloctahydro-1h-2-pyrindine Withdrawn DE2748466A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
DE2748466A1 true DE2748466A1 (de) 1978-05-03

Family

ID=24965981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772748466 Withdrawn DE2748466A1 (de) 1976-11-02 1977-10-28 4a-aryloctahydro-1h-2-pyrindine

Country Status (26)

Country Link
JP (1) JPS5356669A (ro)
AR (1) AR223454A1 (ro)
AT (1) ATA782177A (ro)
AU (1) AU513679B2 (ro)
BE (1) BE860314A (ro)
CA (1) CA1100136A (ro)
CS (1) CS211380B2 (ro)
DD (1) DD133795A5 (ro)
DE (1) DE2748466A1 (ro)
DK (1) DK485277A (ro)
ES (3) ES463784A1 (ro)
FR (1) FR2369267A1 (ro)
GB (1) GB1590155A (ro)
GR (1) GR70053B (ro)
HU (1) HU176231B (ro)
IE (1) IE45901B1 (ro)
IL (1) IL53236A0 (ro)
NL (1) NL7712053A (ro)
NZ (1) NZ185539A (ro)
PH (1) PH12590A (ro)
PL (3) PL108466B1 (ro)
PT (1) PT67194B (ro)
RO (3) RO72900A (ro)
SE (3) SE7712218L (ro)
SU (3) SU812174A3 (ro)
ZA (1) ZA776497B (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020158A1 (en) * 1994-12-23 1996-07-04 Smithkline Beecham Corporation 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189230A (en) * 1977-12-27 1981-05-15 Lilly Co Eli Trans-4a-aryl-2-substituted-octahydro-1h-2-pyrindines
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
PL2670752T3 (pl) 2011-02-02 2016-09-30 Pirolopirazynowe spirocykliczne piperydynoamidy jako modulatory kanałów jonowych
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
CA2829803A1 (en) 2011-03-14 2012-09-20 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020158A1 (en) * 1994-12-23 1996-07-04 Smithkline Beecham Corporation 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
US5892098A (en) * 1994-12-23 1999-04-06 Smithkline Beecham Corporation 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds

Also Published As

Publication number Publication date
ZA776497B (en) 1979-06-27
IE45901B1 (en) 1982-12-29
SU845777A3 (ru) 1981-07-07
PL201885A1 (pl) 1978-12-04
RO78300A (ro) 1982-04-12
SE8103107L (sv) 1981-05-18
PL108610B1 (en) 1980-04-30
IL53236A0 (en) 1977-12-30
NL7712053A (nl) 1978-05-05
SU913941A3 (en) 1982-03-15
PL109690B1 (en) 1980-06-30
SE7712218L (sv) 1978-05-02
AU513679B2 (en) 1980-12-18
PH12590A (en) 1979-06-27
PT67194A (en) 1977-11-01
IE45901L (en) 1978-05-02
NZ185539A (en) 1979-12-11
ES463784A1 (es) 1978-06-16
GR70053B (ro) 1982-07-26
CS211380B2 (en) 1982-02-26
FR2369267A1 (fr) 1978-05-26
FR2369267B1 (ro) 1980-05-16
RO72900A (ro) 1981-11-04
SE8103106L (sv) 1981-05-18
PL108466B1 (en) 1980-04-30
AU3023577A (en) 1979-05-10
CA1100136A (en) 1981-04-28
HU176231B (en) 1981-01-28
BE860314A (fr) 1978-04-28
DK485277A (da) 1978-05-03
AR223454A1 (es) 1981-08-31
RO77935A (ro) 1981-12-25
DD133795A5 (de) 1979-01-24
JPS5356669A (en) 1978-05-23
SU812174A3 (ru) 1981-03-07
ATA782177A (de) 1981-10-15
GB1590155A (en) 1981-05-28
ES472276A1 (es) 1979-10-01
ES463783A1 (es) 1979-07-16
PT67194B (en) 1979-03-23

Similar Documents

Publication Publication Date Title
DE60030883T2 (de) Verfahren zur herstellung von alfentanil, sufentanil und remifentanil
EP0222191B1 (de) 4-Benzyl-1-(2H)-phthalazinon-Derivate
CH648553A5 (de) Neue 3,4-dihydro-5h-2,3-benzodiazepin-derivate und verfahren zur herstellung derselben.
DE2411382B2 (de) 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
DE2002840A1 (de) 2,3,5-trisubstit,-2'-Hydroxy-6,7-benzomorphane und Verfahren zu deren Herstellung
DD264919A5 (de) Verfahren zur herstellung von 5-hydroxy-3-aminochromanen
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
DE2719211C3 (de) 1-(2-Phenylamino-äthyl)-4-(N-phenyl-N-propionylamino)-piperidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2524054A1 (de) 1-cycloalkylmethyl-3a-(substituiertes-phenyl)-decahydroisochinoline
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE1518452C3 (de) 4 substituierte 2 Benzhydryl 2 butanol Derivate und Verfahren zu ihrer Herstellung
CH639368A5 (de) Verfahren zur herstellung von 1-methyl-2-benzylpyrrolidinen.
EP0033156A2 (de) 1-Phenyl-2-cyclohexen-1-alkylamin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2524053A1 (de) 1-aethyl-3a-substituiertes-phenyl- decahydroisochinoline
DE2044172C3 (de) Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel
EP0705830A1 (de) 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als selektive Kaliumkanalmodulatoren
DD141156A5 (de) Verfahren zur herstellung von 4a-aryl-octahydro-1h-2-pyrindinen
DE2159324C2 (de) Benzobicycloalkanamine,-aminoxide, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, welche diese Verbindungen enthalten
EP0082461A2 (de) Substituierte Phenoxyalkanolamine und Phenoxyalkanol-cycloalkylamine, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Zubereitungen und Zwischenprodukte
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE3226921A1 (de) Neue bicyclische verbindungen und verfahren zu ihrer herstellung
DE2551235C3 (de) Aryloxyalkylpiperidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2354931C2 (de) trans-2-Phenylbicyclooctan-Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE3520104A1 (de) Naphthoxazine, ihre herstellung und verwendung

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee
8128 New person/name/address of the agent

Representative=s name: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 800